BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24402870)

  • 1. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK; Wang SP; Lee JY; McGrath JA
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
    Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
    Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
    Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis bullosa: prospects for cell-based therapies.
    Uitto J
    J Invest Dermatol; 2008 Sep; 128(9):2140-2. PubMed ID: 18695685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
    Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
    Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing.
    Nita M; Pliszczyński J; Kosieradzki M; Fiedor P
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1469-1480. PubMed ID: 34269966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis Bullosa: Pediatric Perspectives.
    Hon KL; Chu S; Leung AKC
    Curr Pediatr Rev; 2022; 18(3):182-190. PubMed ID: 34036913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
    Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
    Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral soft tissues in hereditary epidermolysis bullosa.
    Wright JT; Fine JD; Johnson LB
    Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):440-6. PubMed ID: 2052329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long and winding road that leads to a cure for epidermolysis bullosa.
    Carulli S; Contin R; De Rosa L; Pellegrini G; De Luca M
    Regen Med; 2013 Jul; 8(4):467-81. PubMed ID: 23826700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary epidermolysis bullosa: French national guidelines (PNDS) for diagnosis and treatment].
    Chiaverini C; Bourrat E; Mazereeuw-Hautier J; Hadj-Rabia S; Bodemer C; Lacour JP
    Ann Dermatol Venereol; 2017 Jan; 144(1):6-35. PubMed ID: 27931749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015.
    Uitto J; Bruckner-Tuderman L; Christiano AM; McGrath JA; Has C; South AP; Kopelan B; Robinson EC
    J Invest Dermatol; 2016 Feb; 136(2):352-358. PubMed ID: 26802230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational Treatments for Epidermolysis Bullosa.
    Hou PC; Wang HT; Abhee S; Tu WT; McGrath JA; Hsu CK
    Am J Clin Dermatol; 2021 Nov; 22(6):801-817. PubMed ID: 34292508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Conundrum of Allogeneic Bone Marrow Transplantation for Epidermolysis Bullosa.
    Uitto J
    J Invest Dermatol; 2018 May; 138(5):1029-1031. PubMed ID: 29258894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis bullosa dystrophica pretibialis - Clinical snapshot and management of a rare orphan disease.
    Will LM; Reichrath J; Vogt T
    J Dtsch Dermatol Ges; 2021 Jul; 19(7):983-986. PubMed ID: 33951274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders.
    Hünefeld C; Mezger M; Kern JS; Nyström A; Bruckner-Tuderman L; Müller I; Handgretinger R; Röcken M
    Exp Dermatol; 2013 Mar; 22(3):162-7. PubMed ID: 23489418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
    Intong LR; Murrell DF
    Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
    Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
    Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.